Suzie Buono
Illkirch-graffenstaden, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice.
Journal: Neurobiology of disease
Published: January 30, 2024
BIN1 modulation in vivo rescues dynamin-related myopathy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 18, 2022
Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy.
Journal: Disease models & mechanisms
Published: September 06, 2021
Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients.
Journal: Molecular therapy. Methods & clinical development
Published: February 17, 2020
Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Journal: Human molecular genetics
Published: September 09, 2019
Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 07, 2018
Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
Journal: Science translational medicine
Published: August 22, 2018
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
Journal: Nature communications
Published: July 27, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026